Oramed Pharmaceuticals, Inc. (ORMP)

3.88 +0.02 (+0.52%) USD  |  NASDAQ  |  Apr 17, 16:00
3.89 +0.01 (+0.26%) Pre-Market: 20:00
More

Oramed Pharmaceuticals Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for ORMP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Lifeward Ltd. Upgrade
Bristol Myers Squibb Co. Upgrade
Merck & Co., Inc. Upgrade
Instil Bio, Inc. Upgrade
Moderna, Inc. Upgrade